UK markets close in 1 hour 39 minutes

Onconetix, Inc. (ONCO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1529+0.0110 (+7.75%)
As of 09:51AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.1419
Open0.1444
Bid0.1385 x 200
Ask0.1628 x 200
Day's range0.1500 - 0.1599
52-week range0.1000 - 1.3100
Volume45,290
Avg. volume3,967,357
Market cap3.414M
Beta (5Y monthly)3.73
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date20 May 2024 - 24 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

    CINCINNATI, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: ONCO) ("Onconetix" or the “Company”), a commercial stage biotechnology company focused on developing and commercializing therapeutics, diagnostics, and services for clinicians and patients in oncology, today announced the appointment of Ajit Singh, Ph.D. and Thomas Meier, Ph.D. to its Board of Directors. “We are thrilled to announce the addition of Dr. Singh and Dr. Meier to the Board of Directors of Onconetix,” stated Chair